Inhaled hypertonic saline after pediatric lung transplant—Caution required?

Management of pulmonary infection following lung transplant is multifaceted and includes respiratory physiotherapy. Inhaled hypertonic saline (HTS) has been introduced as an adjunct to physiotherapy in pediatric transplant patients. There are no published studies investigating the use of HTS in this...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric transplantation 2020-12, Vol.24 (8), p.e13843-n/a
Main Authors: Shkurka, Emma, Spencer, Helen
Format: Article
Language:English
Subjects:
early post‐operative period
inhalation therapy
Lung transplantation
Lung transplants
Mechanical ventilation
Oxygen
pediatric lung transplant
Pediatrics
Population studies
Statistical analysis
Ventilation
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c3163-13395519f7c752edee937eb57f0cae9c64effd4e15e760dd5d1d30ff55e64463
container_end_page n/a
container_issue 8
container_start_page e13843
container_title Pediatric transplantation
container_volume 24
creator Shkurka, Emma
Spencer, Helen
description Management of pulmonary infection following lung transplant is multifaceted and includes respiratory physiotherapy. Inhaled hypertonic saline (HTS) has been introduced as an adjunct to physiotherapy in pediatric transplant patients. There are no published studies investigating the use of HTS in this population. This study aimed to evaluate the effect of inhaled HTS, in the acute post‐operative period, in pediatric lung transplant patients. A retrospective case‐note review was completed at a single UK pediatric transplant center. An intervention group who received HTS was compared to a historical control group. Participants were frequency matched for age, gender, and diagnosis (14 per group); median age in years was 13.7(IQR 12.7‐15.3) in the controls and 14.8(IQR 12.4‐16.1) in the intervention group. Primary outcome was the requirement of invasive and non‐invasive ventilation. Secondary outcomes included oxygen use and length of stay. Median days of invasive ventilation were shorter in the control group (1, 95% CI 1‐1) compared to the intervention group (2, 95% CI 1‐2.5) (P 
doi_str_mv 10.1111/petr.13843
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2449182170</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2462454997</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3163-13395519f7c752edee937eb57f0cae9c64effd4e15e760dd5d1d30ff55e64463</originalsourceid><addsrcrecordid>eNp90N9KwzAUBvAgipvTGx9ACt6I0Jk0f9pciYypg4kiuy9Zc-I6urZLWmR3PoRP6JOYrdMLLzw3OYQfH4cPoXOCh8TPTQ2NHRKaMHqA-oRKGVLMxOFuj0NKWNRDJ84tMSaCJewY9SjFkRCJ7KOnSblQBehgsanBNlWZZ4FTRV5CoEwDNqhB56qx_rtoy7egsap0daHK5uvjc6TaJq_KwMK6zS3o21N0ZFTh4Gz_DtDsfjwbPYbT54fJ6G4aZpQIGhJKJedEmjiLeQQaQNIY5jw2OFMgM8HAGM2AcIgF1pproik2hnMQjAk6QFddbG2rdQuuSVe5y6DwZ0HVujRiTJIkIjH29PIPXVatLf1xXomIcSZl7NV1pzJbOWfBpLXNV8puUoLTbcfptuN017HHF_vIdr4C_Ut_SvWAdOA9L2DzT1T6Mp69dqHfZNSIQA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2462454997</pqid></control><display><type>article</type><title>Inhaled hypertonic saline after pediatric lung transplant—Caution required?</title><source>Wiley</source><creator>Shkurka, Emma ; Spencer, Helen</creator><creatorcontrib>Shkurka, Emma ; Spencer, Helen</creatorcontrib><description>Management of pulmonary infection following lung transplant is multifaceted and includes respiratory physiotherapy. Inhaled hypertonic saline (HTS) has been introduced as an adjunct to physiotherapy in pediatric transplant patients. There are no published studies investigating the use of HTS in this population. This study aimed to evaluate the effect of inhaled HTS, in the acute post‐operative period, in pediatric lung transplant patients. A retrospective case‐note review was completed at a single UK pediatric transplant center. An intervention group who received HTS was compared to a historical control group. Participants were frequency matched for age, gender, and diagnosis (14 per group); median age in years was 13.7(IQR 12.7‐15.3) in the controls and 14.8(IQR 12.4‐16.1) in the intervention group. Primary outcome was the requirement of invasive and non‐invasive ventilation. Secondary outcomes included oxygen use and length of stay. Median days of invasive ventilation were shorter in the control group (1, 95% CI 1‐1) compared to the intervention group (2, 95% CI 1‐2.5) (P &lt; .05). Days of non‐invasive ventilation and oxygen were higher in the HTS group, but this was not statistically significant. The controls displayed shorter median length of stay (23 days, 95% CI 20‐24) compared to the intervention group (31 days, 95% CI 24.5‐39) (P &lt; .05). The results of this small study provide uncertainty regarding the safety of inhaled hypertonic saline after lung transplant. There was a trend of poorer acute outcomes in patients who received HTS. However, the findings should be interpreted with caution and further investigation using larger samples is required.</description><identifier>ISSN: 1397-3142</identifier><identifier>EISSN: 1399-3046</identifier><identifier>DOI: 10.1111/petr.13843</identifier><identifier>PMID: 33026689</identifier><language>eng</language><publisher>Denmark: Wiley Subscription Services, Inc</publisher><subject>early post‐operative period ; inhalation therapy ; Lung transplantation ; Lung transplants ; Mechanical ventilation ; Oxygen ; pediatric lung transplant ; Pediatrics ; Population studies ; Statistical analysis ; Ventilation</subject><ispartof>Pediatric transplantation, 2020-12, Vol.24 (8), p.e13843-n/a</ispartof><rights>2020 Wiley Periodicals LLC</rights><rights>2020 Wiley Periodicals LLC.</rights><rights>2020 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3163-13395519f7c752edee937eb57f0cae9c64effd4e15e760dd5d1d30ff55e64463</cites><orcidid>0000-0001-7344-6925 ; 0000-0003-2474-3290</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33026689$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shkurka, Emma</creatorcontrib><creatorcontrib>Spencer, Helen</creatorcontrib><title>Inhaled hypertonic saline after pediatric lung transplant—Caution required?</title><title>Pediatric transplantation</title><addtitle>Pediatr Transplant</addtitle><description>Management of pulmonary infection following lung transplant is multifaceted and includes respiratory physiotherapy. Inhaled hypertonic saline (HTS) has been introduced as an adjunct to physiotherapy in pediatric transplant patients. There are no published studies investigating the use of HTS in this population. This study aimed to evaluate the effect of inhaled HTS, in the acute post‐operative period, in pediatric lung transplant patients. A retrospective case‐note review was completed at a single UK pediatric transplant center. An intervention group who received HTS was compared to a historical control group. Participants were frequency matched for age, gender, and diagnosis (14 per group); median age in years was 13.7(IQR 12.7‐15.3) in the controls and 14.8(IQR 12.4‐16.1) in the intervention group. Primary outcome was the requirement of invasive and non‐invasive ventilation. Secondary outcomes included oxygen use and length of stay. Median days of invasive ventilation were shorter in the control group (1, 95% CI 1‐1) compared to the intervention group (2, 95% CI 1‐2.5) (P &lt; .05). Days of non‐invasive ventilation and oxygen were higher in the HTS group, but this was not statistically significant. The controls displayed shorter median length of stay (23 days, 95% CI 20‐24) compared to the intervention group (31 days, 95% CI 24.5‐39) (P &lt; .05). The results of this small study provide uncertainty regarding the safety of inhaled hypertonic saline after lung transplant. There was a trend of poorer acute outcomes in patients who received HTS. However, the findings should be interpreted with caution and further investigation using larger samples is required.</description><subject>early post‐operative period</subject><subject>inhalation therapy</subject><subject>Lung transplantation</subject><subject>Lung transplants</subject><subject>Mechanical ventilation</subject><subject>Oxygen</subject><subject>pediatric lung transplant</subject><subject>Pediatrics</subject><subject>Population studies</subject><subject>Statistical analysis</subject><subject>Ventilation</subject><issn>1397-3142</issn><issn>1399-3046</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp90N9KwzAUBvAgipvTGx9ACt6I0Jk0f9pciYypg4kiuy9Zc-I6urZLWmR3PoRP6JOYrdMLLzw3OYQfH4cPoXOCh8TPTQ2NHRKaMHqA-oRKGVLMxOFuj0NKWNRDJ84tMSaCJewY9SjFkRCJ7KOnSblQBehgsanBNlWZZ4FTRV5CoEwDNqhB56qx_rtoy7egsap0daHK5uvjc6TaJq_KwMK6zS3o21N0ZFTh4Gz_DtDsfjwbPYbT54fJ6G4aZpQIGhJKJedEmjiLeQQaQNIY5jw2OFMgM8HAGM2AcIgF1pproik2hnMQjAk6QFddbG2rdQuuSVe5y6DwZ0HVujRiTJIkIjH29PIPXVatLf1xXomIcSZl7NV1pzJbOWfBpLXNV8puUoLTbcfptuN017HHF_vIdr4C_Ut_SvWAdOA9L2DzT1T6Mp69dqHfZNSIQA</recordid><startdate>202012</startdate><enddate>202012</enddate><creator>Shkurka, Emma</creator><creator>Spencer, Helen</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7344-6925</orcidid><orcidid>https://orcid.org/0000-0003-2474-3290</orcidid></search><sort><creationdate>202012</creationdate><title>Inhaled hypertonic saline after pediatric lung transplant—Caution required?</title><author>Shkurka, Emma ; Spencer, Helen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3163-13395519f7c752edee937eb57f0cae9c64effd4e15e760dd5d1d30ff55e64463</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>early post‐operative period</topic><topic>inhalation therapy</topic><topic>Lung transplantation</topic><topic>Lung transplants</topic><topic>Mechanical ventilation</topic><topic>Oxygen</topic><topic>pediatric lung transplant</topic><topic>Pediatrics</topic><topic>Population studies</topic><topic>Statistical analysis</topic><topic>Ventilation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shkurka, Emma</creatorcontrib><creatorcontrib>Spencer, Helen</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatric transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shkurka, Emma</au><au>Spencer, Helen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhaled hypertonic saline after pediatric lung transplant—Caution required?</atitle><jtitle>Pediatric transplantation</jtitle><addtitle>Pediatr Transplant</addtitle><date>2020-12</date><risdate>2020</risdate><volume>24</volume><issue>8</issue><spage>e13843</spage><epage>n/a</epage><pages>e13843-n/a</pages><issn>1397-3142</issn><eissn>1399-3046</eissn><abstract>Management of pulmonary infection following lung transplant is multifaceted and includes respiratory physiotherapy. Inhaled hypertonic saline (HTS) has been introduced as an adjunct to physiotherapy in pediatric transplant patients. There are no published studies investigating the use of HTS in this population. This study aimed to evaluate the effect of inhaled HTS, in the acute post‐operative period, in pediatric lung transplant patients. A retrospective case‐note review was completed at a single UK pediatric transplant center. An intervention group who received HTS was compared to a historical control group. Participants were frequency matched for age, gender, and diagnosis (14 per group); median age in years was 13.7(IQR 12.7‐15.3) in the controls and 14.8(IQR 12.4‐16.1) in the intervention group. Primary outcome was the requirement of invasive and non‐invasive ventilation. Secondary outcomes included oxygen use and length of stay. Median days of invasive ventilation were shorter in the control group (1, 95% CI 1‐1) compared to the intervention group (2, 95% CI 1‐2.5) (P &lt; .05). Days of non‐invasive ventilation and oxygen were higher in the HTS group, but this was not statistically significant. The controls displayed shorter median length of stay (23 days, 95% CI 20‐24) compared to the intervention group (31 days, 95% CI 24.5‐39) (P &lt; .05). The results of this small study provide uncertainty regarding the safety of inhaled hypertonic saline after lung transplant. There was a trend of poorer acute outcomes in patients who received HTS. However, the findings should be interpreted with caution and further investigation using larger samples is required.</abstract><cop>Denmark</cop><pub>Wiley Subscription Services, Inc</pub><pmid>33026689</pmid><doi>10.1111/petr.13843</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-7344-6925</orcidid><orcidid>https://orcid.org/0000-0003-2474-3290</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1397-3142
ispartof Pediatric transplantation, 2020-12, Vol.24 (8), p.e13843-n/a
issn 1397-3142
1399-3046
language eng
recordid cdi_proquest_miscellaneous_2449182170
source Wiley
subjects early post‐operative period
inhalation therapy
Lung transplantation
Lung transplants
Mechanical ventilation
Oxygen
pediatric lung transplant
Pediatrics
Population studies
Statistical analysis
Ventilation
title Inhaled hypertonic saline after pediatric lung transplant—Caution required?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T23%3A20%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhaled%20hypertonic%20saline%20after%20pediatric%20lung%20transplant%E2%80%94Caution%20required?&rft.jtitle=Pediatric%20transplantation&rft.au=Shkurka,%20Emma&rft.date=2020-12&rft.volume=24&rft.issue=8&rft.spage=e13843&rft.epage=n/a&rft.pages=e13843-n/a&rft.issn=1397-3142&rft.eissn=1399-3046&rft_id=info:doi/10.1111/petr.13843&rft_dat=%3Cproquest_cross%3E2462454997%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3163-13395519f7c752edee937eb57f0cae9c64effd4e15e760dd5d1d30ff55e64463%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2462454997&rft_id=info:pmid/33026689&rfr_iscdi=true